Status:
COMPLETED
Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Ono Pharma USA Inc
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
45-74 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of ONO-5129 in patients with type 2 diabetes mellitus.
Eligibility Criteria
Inclusion
- Fasting Blood Glucose 126-250mg/dL
- HbA1c 6.5-11%
Exclusion
- Previous treatment with antidiabetic agents equal to or less than 2-3 months prior to randomization
- History of myocardial infarction, coronary artery surgery
- Other eligibility criteria as specified in the study protocol
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00335712
Start Date
June 1 2006
Last Update
June 13 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanto Region
Kanto, Japan
2
Kyusyu Region
Kyusyu, Japan